| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
X4 Pharmaceuticals, Inc (XFOR) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. XFOR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 2.33M | $9.60M | - | |
| Pres | 2.33M | $9.60M | - | |
| CFO | 1.55M | $6.40M | - | |
| Dir | 0 | - | - | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 3, 2021 | Ragan Paula77 | President And CEO | Sell | 2,400 | $8.33 | $19,992.00 | -0.6% | -29.5% | -85.0% | |
| Apr 5, 2021 | Ragan Paula77 | President And CEO | Sell | 2,400 | $9.17 | $22,008.00 | -0.6% | -35.9% | -80.9% | |
| Mar 2, 2021 | Ragan Paula77 | President And CEO | Sell | 2,400 | $9.74 | $23,376.00 | -0.9% | - | - | |
| Feb 2, 2021 | Ragan Paula77 | President And CEO | Sell | 2,400 | $7.88 | $18,912.00 | -0.9% | - | - | |
| Jan 5, 2021 | Ragan Paula77 | President And CEO | Sell | 2,400 | $7.00 | $16,800.00 | -0.9% | - | - | |
| Dec 23, 2020 | Ragan Paula77 | President And CEO | Sell | 4,800 | $7.00 | $33,600.00 | -1.7% | - | - | |
| Oct 5, 2020 | Ragan Paula77 | President And CEO | Sell | 1,797 | $7.00 | $12,579.00 | -0.6% | - | - | |
| Oct 2, 2020 | Ragan Paula77 | President And CEO | Sell | 603 | $7.00 | $4,221.00 | -0.2% | - | - | |
| Sep 21, 2020 | Mostafa Adam S.75 | Chief Financial Officer | Sell | 10,834 | $7.08 | $76,704.72 | -26.8% | - | - | |
| Sep 9, 2020 | Skerlj Renato | Chief Scientific Officer | Sell | 5,834 | $8.05 | $46,963.70 | -12.2% | - | - |